Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC264

Doravírín eða lyfjafræðilega viðunandi salt þar af í samsetningu með lamivúdíni og með tenófóvír dísóproxílfúmarati

  • Status:
    Veitt
  • Application date:
    5.4.2019
  • Application published:
    15.5.2019
  • Grant published:
    15.3.2022
  • Max expiry date:
    25.11.2033
  • Medicine name:
    Delstrigo
  • Medicine for children:
    No

Timeline

Today
5.4.2019Application
15.5.2019Publication
15.3.2022Registration
25.11.2033Expires

Marketing license

  • IS authorization number:
    EU/1/18/1333/001-002
  • Date:
    12.12.2018
  • Foreign authorization number:
    EU/1/18/1333/001-002
  • Date:
    22.11.2018

Owner

  • Name:
    Merck Canada Inc.
  • Address:
    16711 Trans-Canada Highway, Kirkland QC H9H 3L1 CA

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents